Immunopathological characteristics of patients with bullous pemphigoid and neurological disease

Journal of the European Academy of Dermatology and Venereology

Volumn 28, Issue 5, 2014, Pages 569-573

  Taghipour, K ^a,b   Chi, C C ^c,d   Bhogal, B ^e   Groves, R W ^a,e   Venning, V ^b   Wojnarowska, F ^f  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^e ST THOMAS HOSPITAL   (United Kingdom)

^f UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AUTOANTIBODY;

ADULT; AGED; ANTIBODY TITER; ARTICLE; BULLOUS PEMPHIGOID; CASE CONTROL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITAL PHYSICIAN; HUMAN; IMMUNE RESPONSE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOPATHOLOGY; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; NEUROLOGIST; PRIORITY JOURNAL; PSYCHIATRIST; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PEMPHIGOID, BULLOUS;

EID: 84899479501     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12136     Document Type: Article

References (18)

1. Taghipour K, Chi CC, Vincent A, Groves RW, Venning V, Wojnarowska F,. The association of bullous pemphigoid with cerebrovascular disease and dementia: a case-control study. Arch Dermatol 2010; 146: 1251-1254.
2. Bastuji-Garin S, Joly P, Lemordant P, et al,. Risk factors for bullous pemphigoid in the elderly: a prospective case-control study. J Invest Dermatol 2011; 131: 637-643.
3. Langan SM, Groves RW, West J,. The relationship between neurological disease and bullous pemphigoid: a population-based case-control study. J Invest Dermatol 2011; 131: 631-636.
4. Chen YJ, Wu CY, Lin MW, et al,. Comorbidity profiles among patients with bullous pemphigoid: a nationwide population-based study. Br J Dermatol 2011; 165: 593-599.
5. Brown A, Dalpe G, Mathieu M, Kothary R,. Cloning and characterization of the neural isoforms of human dystonin. Genomics 1995; 29: 777-780.
6. Leung CL, Zheng M, Prater SM, Liem RK,. The BPAG1 locus: alternative splicing produces multiple isoforms with distinct cytoskeletal linker domains, including predominant isoforms in neurons and muscles. J Cell Biol 2001; 154: 691-697.
7. Bernier G, Brown A, Dalpe G, De Repentigny Y, Mathieu M, Kothary R,. Dystonin expression in the developing nervous system predominates in the neurons that degenerate in dystonia musculorum mutant mice. Mol Cell Neurosci 1995; 6: 509-520.
8. Claudepierre T, Manglapus MK, Marengi N, et al,. Collagen XVII and BPAG1 expression in the retina: evidence for an anchoring complex in the central nervous system. J Comp Neurol 2005; 487: 190-203.
9. Giorda R, Cerritello A, Bonaglia MC, et al,. Selective disruption of muscle and brain-specific BPAG1 isoforms in a girl with a 6;15 translocation, cognitive and motor delay, and tracheo-oesophageal atresia. J Med Genet 2004; 41: e71.
10. Seppanen A, Autio-Harmainen H, Alafuzoff I, et al,. Collagen XVII is expressed in human CNS neurons. Matrix Biol 2006; 25: 185-188.
11. Seppanen A, Suuronen T, Hofmann SC, Majamaa K, Alafuzoff I,. Distribution of collagen XVII in the human brain. Brain Res 2007; 1158: 50-56.
12. Kirtschig G, Walkden VM, Venning VA, Wojnarowska F,. Bullous pemphigoid and multiple sclerosis: a report of three cases and review of the literature. Clin Exp Dermatol 1995; 20: 449-453.
13. Taghipour K, Kirtschig G, Palace J, Groves RW, Venning V, Wojnarowska F,. The association of multiple sclerosis with bullous pemphigoid: is there a shared antigen response? J Am Acad Dermatol 2012; 67: 160-161.
14. Murrell DF, Daniel BS, Joly P, et al,. Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts. J Am Acad Dermatol 2012; 66: 479-485.
15. Bhogal B, Black MM,. Diagnosis, diagnostic and research techniques. In:, Wojnarowska F, Briggaman R, eds. Management of blistering diseases. Chapman & Hall Medical, London, 1990: 15-35.
16. Towbin H, Staehelin T, Gordon J,. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979; 76: 4350-4354.
17. Dowling J, Yang Y, Wollmann R, Reichardt LF, Fuchs E,. Developmental expression of BPAG1-n: insights into the spastic ataxia and gross neurologic degeneration in dystonia musculorum mice. Dev Biol 1997; 187: 131-142.
18. Chen J, Li L, Zeng Y, Xu H, Song Y, Wang B,. Sera of elderly bullous pemphigoid patients with associated neurological diseases recognize bullous pemphigoid antigens in the human brain. Gerontology 2011; 57: 211-216.